Mass spectrometry-based proteomics identify novel serum osteoarthritis biomarkers

Abstract Background Osteoarthritis (OA) is a slowly developing and debilitating disease, and there are no validated specific biomarkers for its early detection. To improve therapeutic approaches, identification of specific molecules/biomarkers enabling early determination of this disease is needed....

Full description

Bibliographic Details
Published in:Arthritis Research & Therapy
Main Authors: Ginette Tardif, Frédéric Paré, Clarisse Gotti, Florence Roux-Dalvai, Arnaud Droit, Guangju Zhai, Guang Sun, Hassan Fahmi, Jean-Pierre Pelletier, Johanne Martel-Pelletier
Format: Article
Language:English
Published: BMC 2022-05-01
Subjects:
Serum biomarkers
Proteomics
Osteoarthritis
Mass spectrometry
Online Access:https://doi.org/10.1186/s13075-022-02801-1

Internet

https://doi.org/10.1186/s13075-022-02801-1

Similar Items